Background: Lateral epicondylitis is a common cause of elbow pain that is treated with a variety of nonoperative measures and often improves with time. Minimal research is available on patients in whom these nonoperative treatments fail.
Lateral epicondylitis is a common cause of elbow pain, affecting 1% to 3% of the adult population each year. 22 The cause of lateral epicondylitis is unknown, although a history of manual labor and repetitive activities often precedes the onset of the condition. 10 Rather than an inflammatory response, repetitive microtrauma to the extensor carpi radialis brevis tendon causes vascular hyperplasia and an accumulation of disorganized collagen, termed angiofibroblastic hyperplasia. 1 Lateral epicondylitis often improves with time, with approximately 80% of patients reporting resolution of symptoms within 1 year of diagnosis. 9, 19 A variety of nonoperative methods have been proposed as treatment, including nonsteroidal anti-inflammatory medications, steroid injections, and orthotic devices. 7, 21 Physicians often recommend physical therapy, activity modification, or periods of rest to promote healing. Despite these common treatment measures, a standardized treatment protocol is not available for lateral epicondylitis to mitigate symptoms, speed recovery, or promote healing. Surgical intervention for lateral epicondylitis is typically reserved for patients with persistent pain after 6 to 12 months of nonoperative treatment. 4, 7, 19 Surgery entails 5-in-5 debridement of the diseased tissue within the extensor carpi radialis brevis and occasionally the extensor digitorum communis through open or arthroscopic techniques. Various studies report improved postoperative symptoms in more than 80% of patients. 8, 16 While an extended nonoperative treatment approach is well accepted, there is concern that patients who ultimately require surgery may have unnecessarily prolonged the period of pain and dysfunction while pursuing nonoperative modalities. The primary aim of this study was to identify factors associated with the failure of nonoperative treatment of lateral epicondylitis. Our hypothesis was that both disease-specific factors (ie, increased symptom duration) and patient-specific factors (ie, workers' compensation coverage) would predict the failure of nonoperative treatment. The null hypothesis was that all patient and disease factors would occur with similar frequency in the nonoperative success group compared with the nonoperative failure group.
METHODS
This retrospective case-control investigation was approved by our institutional review board. We identified all adult patients treated for lateral epicondylitis by International Classification of Diseases, 9th Revision (ICD-9) code (726.32) at our tertiary care institution from 2007 to 2012. All patients aged 30 years or older with the diagnosis of lateral epicondylitis and without prior surgical treatment for lateral epicondylitis or radial tunnel syndrome were eligible for inclusion in the study. The diagnosis of lateral epicondylitis was confirmed during manual review of all medical records selected by ICD-9 code. All patients selected to contribute to data analysis were explicitly diagnosed with lateral epicondylitis by attending treating surgeons based on patient history and physical examination. Lateral epicondylitis was diagnosed by suggestive patient history and point tenderness at the origin of the extensor carpi radialis brevis from the lateral epicondyle. Radial tunnel syndrome was diagnosed on the criteria described previously by Verhaar and Spaans. 23 Affected patients had a suggestive history of pain in the proximal radial part of the forearm that was aggravated by work but also present at rest. On examination, patients demonstrated point tenderness over the posterior interosseous nerve, with maximal tenderness elicited at the point where the nerve passes under the proximal edge of the supinator muscle, anterior and approximately 5 cm distal to the lateral epicondyle.
Statistical Methods
Descriptive statistics (frequencies for dichotomous variables) were used to characterize baseline characteristics. Univariate analysis was performed on all variables collected, testing for statistical significance with Student t test for continuous independent variables and chi-square or Fisher exact test for categorical variables. From the univariate analysis, odds ratios (ORs) were calculated for all categorical variables.
Variables that were associated with failure of nonoperative treatment (P \ .1) were entered into a multivariable logistic regression analysis, using a backward stepwise method. Interaction terms were created to test for the possibility of effect modification between ''affected arm'' and ''dominant arm'' and between all treatments occurring before presentation (prior injection, prior physical therapy, prior splinting). Model explanatory power was assessed using the Hosmer-Lemeshow goodness-of-fit statistical test. Statistical significance was set at the a = .05 level for all tests.
RESULTS
A total of 664 patients were identified in our billing database, and manual chart review excluded 84 patients who did not have lateral epicondylitis or who had undergone prior surgery for lateral epicondylitis. Therefore, 580 patients were included for analysis. Baseline patient characteristics and disease-specific factors that were recorded are listed in Table 1 . If a patient developed bilateral symptoms during treatment, only the initial side was included in this analysis.
In our cohort of 580 patients, 92 (16%) underwent surgical treatment, leaving 488 nonoperative controls for comparison.
Baseline Patient-Specific Characteristics
Our study population included 242 men and 338 women. The mean (6SD) age was 47 6 9.3 years (range, 30-83 years). A majority of the patients were nonsmokers (n = 489; 84%), nondiabetic (n = 533; 92%), married (n = 404; 70%), and nonlaborers (n = 373; 64%). Fifty-three patients (9%) had their treatment paid for through the Office of Workers' Compensation Programs. Most patients did not use antianxiety (n = 526; 91%), narcotic (n = 504; 87%), or antidepressant (n = 469; 81%) medications. Almost half of our patients had undergone prior orthopaedic surgery (n = 282; 49%). No patient had undergone previous surgery for lateral epicondylitis.
Baseline Disease-Specific Characteristics
The mean duration of symptoms at presentation to our practice was 8 months. At presentation to our practice, 122 patients (21%) had already been treated with physical therapy, 145 patients (25%) had been treated with a splint, and 96 patients (17%) had been treated with an injection. Ninety-seven patients (17%) had concurrent ipsilateral radial tunnel syndrome, diagnosed by their treating surgeon in our practice at their initial visit.
Multivariate Model
The final multivariable regression model included the following patient-specific factors that demonstrated a potential association with surgery during univariate analysis: age, body mass index, smoking, use of narcotics, use of antidepressant medications, workers' compensation claim, a labor occupation, and previous orthopaedic surgery ( Table 1) . Disease-specific factors that demonstrated a potential association with surgery during univariate analysis and were included in the final multivariate model included duration of symptoms longer than 12 months, concomitant radial tunnel syndrome, prior injection, therapy, and prior splinting. An interaction term, which was created to evaluate the effect of handedness with laterality of symptoms and surgery, showed no effect. Interaction terms were also created to evaluate the possibility of significant correlation between variables related to prior treatment. Interactions between prior injection, prior therapy, and prior splinting were all found to be insignificant.
The final multivariable regression model identified the presence of radial tunnel syndrome, workers' compensation, previous injection, duration of symptoms greater than 12 months, and previous orthopaedic surgery as factors that remained independently predictive of failure of nonoperative treatment ( Table 2 ). The overall model was statistically significant (likelihood ratio x 2 = 167.554, df = 11, P \ .001). The Hosmer-Lemeshow lack of fit test (x 2 = 4.435, P = .816) indicated acceptable model fit to the data.
DISCUSSION
Lateral epicondylitis is generally considered a self-limiting problem best treated with a course of nonoperative treatment since most patients improve within 1 year. 5, 19 There is no standard nonoperative regimen that has proven superiority, leading to considerable variation in nonoperative treatment protocols. 1,3 However, we theorized that there may be baseline patient and disease characteristics identified at the time of presentation to an orthopaedic surgeon that can be used to predict response to nonoperative treatment. This information could be helpful when discussing expectations of symptom relief after nonoperative treatment with patients.
In this study, 16% of patients underwent surgery. Few studies have reported on surgical rates for lateral epicondylitis. Nirschl and Pettrone 16 reported that 7.2% of their cohort of 1213 subjects eventually underwent surgery. Coonrad and Hooper 5 reported that 11.5% of their 339 patients failed nonoperative treatment and underwent surgery. In comparison with these single-center reports, Sanders et al 17 underwent surgery. The differences in surgical rates likely reflect the differences in patient population, with a population-based study likely having a higher proportion of mild cases when compared with cases at an upper extremity specialty practice. Our higher surgical rate likely reflects the fact that a large proportion of our patient population had sought treatment before presentation. The mean duration of symptoms for our entire cohort (both surgical and nonsurgical) was 8 months. More than 50% of our surgical group had a failed corticosteroid injection with another physician before seeking care in our practice. For these reasons, the surgical rate reported in this study may lack widespread generalizability, although similar surgical rates may be expected in a similar tertiary care, upper extremity referral center. In addition, limited data are available to inform practitioners about the prognosis of treatment in patients with lateral epicondylitis. Haahr 9 showed that patients with a higher severity of pain and patients who were manual laborers had a worse prognosis at 1 year after diagnosis, regardless of treatment. This contrasts with the findings of this study, as we did not find manual labor to be predictive of failure of nonoperative treatment. Similar to the findings of Haahr, we found that patient sex, age, and increased body mass index were not prognostic of outcome at 1-year follow-up. Other studies have shown factors such as smoking, repetitive upper extremity activity, and obesity to be risk factors for the development of lateral epicondylitis but not necessarily associated with failed treatment. 18, 24 Our model showed duration of symptoms greater than 12 months before presentation and presence of ipsilateral radial tunnel syndrome to be predictors of failure of nonoperative treatment. Prolonged duration of symptoms may indicate a severe case of lateral epicondylitis less amenable to nonoperative treatment. Alternatively, this may simply reflect that for most practitioners, 12 months of symptom duration is an indication for surgery. Concomitant radial tunnel syndrome is thought to contribute to the morbidity of chronic lateral epicondylitis, and patients affected by both diagnoses have a worse outcome despite surgical treatment. 11, 15 Patients with concomitant radial tunnel syndrome may have a higher severity of lateral elbow symptoms and therefore fare worse with nonoperative treatment, as our model suggests.
Consistent with previous studies in the orthopaedic surgery literature, a workers' compensation claim was a strong risk factor for failure of nonoperative treatment. 12, 20, 24 In our study, history of injection was predictive of failure of nonoperative treatment. Injections, whether corticosteroid, autologous blood, prolotherapy, platelet-rich plasma, or botulinum toxin, have not been shown to be more effective than placebo in treating lateral epicondylitis. 1, 14, 20, 25 On the basis of the data available, we cannot determine whether corticosteroid injection before presentation was associated with eventual surgery because injection, regardless of when it is administered, affects rates of eventual symptom recurrence. It is plausible that prior injection was a proxy for increased symptom severity, which may in turn portend a worse response to nonoperative treatment.
Psychological factors, such as depression, have previously been shown to influence outcome measures in upper extremity surgery. 6, 13 A previous study showed higher levels of anxiety and depression in patients with lateral epicondylitis compared with healthy controls. 2 In our study, the use of antidepressants approached significance (P = .069) in the univariate analysis but did not remain significant in the final multivariate model. It is possible that directly screening our patients for depression, rather than noting the use of antidepressive medications, would have demonstrated an influence on treatment of lateral epicondylitis as there may have been patients either who were undiagnosed or who were not being treated for their depression or anxiety with medications.
Patients with a history of orthopaedic surgery were more likely to fail nonoperative treatment in our model. To our knowledge, this is the first report demonstrating that a patient's prior orthopaedic surgery is associated with increased odds of undergoing surgery for lateral epicondylitis. Patients who have undergone prior surgeries may be more likely to consider or want surgical intervention compared with patients without any surgical history. As our study was not designed to establish the reasons for the observed associations, further study is needed.
A limitation of our study is the retrospective nature of our database. Confounding variables may have been present that were not collected or contained in the medical record. In particular, it is unknown how patient activity level may have affected patient response to nonoperative treatment. In addition, we chose a minimum age of 30 years, which may have led to loss of important descriptive cohort information. We decided on this age to minimize the possibility of including patients with an acute injury or acute tendinitis, both of which are distinct from the chronic, degenerative tendinosis that is a hallmark of tennis elbow. Also, there is a possibility that some patients followed up with another practice for surgery, which would detract from our ability to assess the effectiveness of nonoperative treatment. Surgery was chosen as a marker for failed nonoperative treatment because it offered a clear, objective criterion on which to separate and compare groups. Nonetheless, we recognize that this definition does not preclude the possibility that some patients treated nonoperatively may have had continued symptoms. The database also did not capture severity of lateral epicondylitis, which may be a predictor of failure of nonoperative treatment. We captured patients based on Current Procedural Terminology (CPT) code rather than uniform diagnostic criteria of lateral epicondylitis. Future prospective studies would benefit from better documentation of symptom severity and posttreatment symptom resolution through the use of validated patient outcome scores such as the Patient Rated Tennis Elbow Evaluation (PRTEE).
CONCLUSION
The treatment for lateral epicondylitis can be long and frustrating for patients, especially since there is not a standard superior treatment. With these data, we now counsel our patients that while only 16% of patients ultimately need surgery, the risk of needing surgery to relieve symptoms is significantly higher among patients with concomitant radial tunnel syndrome, a prior injection, prior orthopaedic surgery, or a workers' compensation claim.
